cancerA large number of clinical trials have been conducted in lung cancer, but very few surveys have attempted to assess their impact on actual clinical practice. A questionnaire was therefore designed to address this question, and, in addition, to collect information on the numbers of patients ...
Clinical research in non-small-cell lung cancer (NSCLC) is a rapidly evolving field. In an effort to identify current trends in lung cancer clinical researches, Subramanianet al. reviewed ongoing clinical trials in NSCLC registered onClinicalTrials.govin 2012. Comparing the data with a similar su...
Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment. Multidiscip Respir Med. 2011;6(1):20-7. doi:10.1186/ 2049-6958-6-1-20.Bojan, ZaricBranislav, PerinAleksandra, IlicIvan, KopitovicJovan, MatijasevicLjiljana, AndrijevicNevena, SecenJelena, ...
Lung Cancer Clinical TrialsThese are research studies being performed to improve the standard of existing treatment. Lung cancer clinical trials are conducted to test the role of genomics in treatment of non-small lung cancer.Clinical trials involve innovative diagnostic technologies, surgical and...
strategies and partnerships to bring these trials to patients living outside of Montreal and major urban centers," says Dr. Spicer, who is also an associate professor of surgery at McGill University and an internationally renowned expert on novel therapies for patients with resectable lung cancer. ...
Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), according to researchers at The University of Texas MD Anderson Cancer Center....
Clinical trials offer innovative therapeutic options with potentially better outcomes, but their effects on health care costs are disputed.METHODSThe authors analyzed the 1-year facility-based treatment cost and survival of 336 newly diagnosed nonsmall cell lung cancer patients who were deemed eligible ...
Treatment Paradigms for Advanced Non‐Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design Based on the positive results of various clinical trials, treatment options for non-small cell lung cancer (NSCLC) have expanded greatly over the last 25 y... C...
A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS or NRAS MutationLUNG CANCER TRIALSAVANZAR...
We summarize the ongoing international and domestic clinical trials using PD-1 and PD-L1 inhibitors to treat lung cancer. This information can help researchers better understand the active and approved clinical trials in China, as well as the ongoing research regarding PD-1 and PD-L1 inhibitors....